Toxins of Clostridium perfringens as a natural and bioterroristic threats;Toksyny Clostridium perfringens jako zagrożenie naturalne i bioterrorystyczne

Polski Merkuriusz Lekarski

Volumn 39, Issue 231, 2015, Pages 149-152

  Omernik, Andrzej ^a   Płusa, Tadeusz ^a  

^a CENTRAL CLINICAL HOSPITAL OF THE MINISTRY OF NATIONAL DEFENSE   (Poland)

Author keywords

bioterrorism; Clostridium perfringens; epsilon toxin

Indexed keywords

BACTERIAL TOXIN; BIOLOGICAL WARFARE AGENT;

BIOLOGICAL WARFARE AGENT; BIOTERRORISM; CHEMICALLY INDUCED; CLOSTRIDIUM PERFRINGENS; FOOD POISONING; GAS GANGRENE; HUMAN; MICROBIOLOGY; NECROTIZING ENTEROCOLITIS;

BACTERIAL TOXINS; BIOLOGICAL WARFARE AGENTS; BIOTERRORISM; CLOSTRIDIUM PERFRINGENS; ENTEROCOLITIS, NECROTIZING; FOODBORNE DISEASES; GAS GANGRENE; HUMANS;

EID: 84953342840     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Balali-Mood M, Moshiri M,Etemad L.: Medical aspects of bio-terrorism. Toxicon, 2013; 69:131-142.
2. Bokori-Brown M, Kokkindou MC, Sava ChG, et al.: Clostridium perfringens epsilon toxin H149A mutant as a platform for receptor binding studies. Protein Sci, 2013; 22:650-6599.
3. Clarke SC.: Bacteria as potential tools in bioterrorism with an emphasis in bacterial toxins. Br J Biomed Sci, 2005;62:40-46.
4. Dwivedi P, Alam SI, Kumar O.: Lipoproteins from Clostridium perfringens and they protective efficacy in mouse model. Infect Genet Envol, 2015;28: pii: S1567-1348(15)00213-0. doi: 10.1016/j.meegid. 2015. 05. 029.
5. Dziubek Z.: Zakażenia wywołane przez bakterie Gram-dodatnie. - w - Dziubek Z. (red.): Choroby zakaźne i pasożytnicze, PZWL, Warszawa, 2000:116-118.
6. Gaur K, Iyer K, Pola S, et al.: The Clostridium perfringens epsilon toxin as a bioterrorism weapon. J Microb Biochem Technol, 2014; S8: 009. doi:10.4172/1948-5948.S8-009.
7. Gras JE, Gould LH, Mahon BE.:Epidemiology of foodborne disease outbreaks caused by Clostridium perfringens, United States, 1998-2010. Foodborne Pathog Dis, 2013;10:131-136.
8. Ho H.: Gas gangrene. http://emedicine.medscape.com/article/217943overview#a6, last update dec. 2013.
9. Kawecki M, Knefel G, Szymańska B, et al.: Aktualne wskazania i możliwości zastosowania terapii tlenowej. Balneol Pol, 2006; 4:202-206.
10. Kądzielska J, Obuch-Woszczatyńki P, Pituch H, i wsp.: Clostridium perfringens jako czynnik etiologiczny biegunki poantybiotykowej. Post Mikrobiol, 2012; 51:17-25.
11. Mathieu D, Schmutz J, Cronje F.: Indication for HBO. – in – Mathieu D. (ed.): Handbook on hyperbaric. Springer, 2006:163-170.
12. Posobkiewicz M. (red.): Stan sanitarny kraju w 2014 roku. wwwgis.gov.pl
13. Public Health Agency of Canada: Clostridium perfringens. Pathogen Safety Data Sheat- Infectious Substances 2012: http://www.phac-aspc.gc.ca/lab-bio/res/psds-ftss/clostridium-perfringens-eng.php
14. Stevens DL, Bisno AL, Chambers HF, et al.: Practice guidelines for the diagnosis and management of skin and soft tissue infections. 2014 Update by the Infectious Diseases Society of America, 2014, 15;59(2): e10-52. doi: 10.1093/cid/ciu444.
15. The Center for Food Security & Public Health, Institute for International Cooperation in Animal Biologics Iowa State University: Epsilon Toxin of Clostridium perfringens. http://www.cfsph.iastate.edu/Factsheets/pdfs/epsilon_toxin_clostridium.pdf, ostatnie uaktualnienie 2004 r.
16. Ziółko A.: Procedura postępowania w szpitalu w przypadku wystąpienia zgorzeli gazowej. Biuletyn, 2007;1-2: 15-20.